Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Rang in aandelen #28150
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Aandeelprijs
$1.40
Laatst gesynchroniseerd: 2026-08-18
Marktkapitalisatie
$28.25M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
536.36%
Land
IL
Handel Raphael Pharmaceutical Inc. (RAPH)

Categorie

Dividendrendementgeschiedenis voor Raphael Pharmaceutical Inc. (RAPH)
Het dividendrendement (TTM) van Raphael Pharmaceutical Inc. (aandelsymbool: RAPH) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Raphael Pharmaceutical Inc. (RAPH) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten